Merz Pharma

merz.com

With approximately 3,000 employees and 34 subsidiaries worldwide, Merz has evolved as a leading provider of aesthetics and special neurology. Privately held for more than 100 years, the company is distinguished by its innovative in-house R&D, solid financial strength and the right strategy for long-term growth.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

ALNYLAM ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR OXLUMO® (LUMASIRAN) IN ADVANCED PRIMARY HYPEROXALURIA TYPE 1

Alnylam Pharmaceuticals, Inc. | October 07, 2022

news image

Alnylam Pharmaceuticals, Inc. the leading RNAi therapeutics company, announced that the U.S. Food and Drug Administration approved a label expansion for OXLUMO® an RNAi therapeutic administered via subcutaneous injection, now indicated for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate and plasma oxalate levels in pediatric and adult patients. The approval is based on positive efficacy and safety results of the ILLUMINATE-C Phase 3 study of OXLUMO in patients wi...

Read More

Business Insights

AZZUR GROUP ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Azzur Group, LLC | January 13, 2022

news image

To support rapid company growth and best meet the demands of the business, Azzur Group announces new executive leadership appointments. Originally founded in Philadelphia in 2010, Azzur is a market-leading provider of GxP services for the pharmaceutical, biotechnology, medical device, and healthcare industries with offices and on-demand cleanrooms locations throughout the United States. Today, the organization provides comprehensive GxP solutions through its on-demand cleanrooms, consulting and ...

Read More

Pharmacy Market

ULTIVUE ANNOUNCES CO-MARKETING AGREEMENT WITH AIGNOSTICS FOR UNIQUE SPATIAL AI-POWERED IMAGING SOLUTIONS FOR TRANSLATIONAL MEDICINE

Ultivue, Inc., | March 10, 2022

news image

Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Aignostics GmbH, a global leader in Artificial Intelligence (AI) powered precision diagnostics focused on pathology to assist with research, clinical trials and CDx development, announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma. The companie...

Read More

DRUG SHORTAGES IN US MARKET, COMPLIANCE GAINS POSITIVE FOR PHARMA EXPORTERS

Business-standard | April 23, 2020

news image

Concerns over price erosion in the US market, which has impacted the revenue growth of Indian pharma majors over the last four years, could be reversing. The drug shortages in the US market have increased by 37 per cent since December 2017. Kunal Randeria of Antique Stock Broking says drug shortages are at five-year highs and there is a direct correlation between drug shortage and prices. This is evident as price erosion peaked in 2017 when shortages were at their lowest levels. Concerns over pr...

Read More
news image

Pharmacy Market

ALNYLAM ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR OXLUMO® (LUMASIRAN) IN ADVANCED PRIMARY HYPEROXALURIA TYPE 1

Alnylam Pharmaceuticals, Inc. | October 07, 2022

Alnylam Pharmaceuticals, Inc. the leading RNAi therapeutics company, announced that the U.S. Food and Drug Administration approved a label expansion for OXLUMO® an RNAi therapeutic administered via subcutaneous injection, now indicated for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate and plasma oxalate levels in pediatric and adult patients. The approval is based on positive efficacy and safety results of the ILLUMINATE-C Phase 3 study of OXLUMO in patients wi...

Read More
news image

Business Insights

AZZUR GROUP ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Azzur Group, LLC | January 13, 2022

To support rapid company growth and best meet the demands of the business, Azzur Group announces new executive leadership appointments. Originally founded in Philadelphia in 2010, Azzur is a market-leading provider of GxP services for the pharmaceutical, biotechnology, medical device, and healthcare industries with offices and on-demand cleanrooms locations throughout the United States. Today, the organization provides comprehensive GxP solutions through its on-demand cleanrooms, consulting and ...

Read More
news image

Pharmacy Market

ULTIVUE ANNOUNCES CO-MARKETING AGREEMENT WITH AIGNOSTICS FOR UNIQUE SPATIAL AI-POWERED IMAGING SOLUTIONS FOR TRANSLATIONAL MEDICINE

Ultivue, Inc., | March 10, 2022

Ultivue, Inc., an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Aignostics GmbH, a global leader in Artificial Intelligence (AI) powered precision diagnostics focused on pathology to assist with research, clinical trials and CDx development, announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma. The companie...

Read More
news image

DRUG SHORTAGES IN US MARKET, COMPLIANCE GAINS POSITIVE FOR PHARMA EXPORTERS

Business-standard | April 23, 2020

Concerns over price erosion in the US market, which has impacted the revenue growth of Indian pharma majors over the last four years, could be reversing. The drug shortages in the US market have increased by 37 per cent since December 2017. Kunal Randeria of Antique Stock Broking says drug shortages are at five-year highs and there is a direct correlation between drug shortage and prices. This is evident as price erosion peaked in 2017 when shortages were at their lowest levels. Concerns over pr...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us